Article Versions Notes

van den Bosch QCC, Nguyen JQN, Brands T, van den Bosch TPP, Verdijk RM, Paridaens D, Naus NC, de Klein A, Kiliç E, Brosens E on behalf of the Rotterdam Ocular Melanoma Study Group . FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma. Cancers. 2022; 14(15):3668. https://doi.org/10.3390/cancers14153668

van den Bosch, Quincy C. C., Josephine Q. N. Nguyen, Tom Brands, Thierry P. P. van den Bosch, Robert M. Verdijk, Dion Paridaens, Nicole C. Naus, Annelies de Klein, Emine Kiliç, and Erwin Brosens on behalf of the Rotterdam Ocular Melanoma Study Group . 2022. "FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma" Cancers 14, no. 15: 3668. https://doi.org/10.3390/cancers14153668

van den Bosch, Q. C. C., Nguyen, J. Q. N., Brands, T., van den Bosch, T. P. P., Verdijk, R. M., Paridaens, D., Naus, N. C., de Klein, A., Kiliç, E., & Brosens, E., on behalf of the Rotterdam Ocular Melanoma Study Group . (2022). FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma. Cancers, 14(15), 3668. https://doi.org/10.3390/cancers14153668